Research Interest

Tissue regeneration, Cancer, Diabetes, Alzheimer’s disease, Parkinson’s disease

Biography

Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world. In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Switzerland and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped within three days. CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin the cure for non-healing wounds was discovered and that led to repairing nerves and pain release. Professor Hague is the owner of CellSonic Limited and advises the Universities of Bradford in England and Hyderabad in India.

Research Interest

Pediatrics, Neonatologist, Molecular Genetics

Research Interest

Anesthesia

Research Interest

Biological & Environmental Sciences

Research Interest

TMJ Diseases, Alloplastic TMJ Reconstruction, Dentofacial Deformities

Biography

Dr. Eber Luis Stevao (DDS, S.Ed, PhD - Oral and Maxillofacial surgeon) was born in Southern Brazil in the year of 1968. He graduated from Pontifical Catholic University of Parana, School of Dentistry, Curitiba - Brazil, obtaining a DDS degree. He completed his post-graduation studies in Teachings and Didactics and received the title of "Specialist in Advanced Education”. After his Residency training in Oral and Maxillofacial Surgery from 1995 thru 1999. During the residency he started his Doctorate in OMS receiving his Ph.D. degree from Pontifical Catholic University of Rio Grande do Sul, School of Dentistry, Porto Alegre - Brazil. His thesis was about Bone Repair. In 2001 he was accepted for a 2-full year training in OMS at Baylor University Medical Center, Dallas - TX under Dr. Larry Wolford´s tutelage. At the end of 2003 Dr. Stevao brought to Brazil the TMJ Surgical Prosthesis technique and legalized the TMJ total joint prosthesis (TMJ Concepts System) being the first surgeon to perform a science-based TMJ total joint alloplastic replacement in Brazil. In 2008 he was the first South American to enter the reclusive American Society of Temporomandibular Surgeons (ASTMJS). Besides his three already published books he wrote, edited and published the very first illustrative text-book about TMJ Surgery launched in 2014, Chicago, Illinois and has several publications in international journals. He successfully completed the NBDE I, II and NERB in 2015 in the USA obtaining the title of Doctor of Dental Surgery. Since 2016 Dr. Stevao is an invited OMF surgeon at Elisabeth-Stiftung Hospital in Birkenfeld and at Professor Maure´s Praxisklinik in Sankt Wendel, Germany where he consult and operate patients every three months. In 2018 he became board licensed in the State of Ohio. He has been invited to lecture all over the world about complex Oral and Maxillofacial Surgery.

Research Interest

Microbiology, Biochemistry

Biography

Robert L Sautter completed his BS and MS degrees at Eastern Michigan University and he graduated majoring in Microbiology from Wayne State University with a PhD in 1982. He is the principle for RL Sautter Consulting LLC in Lancaster, SC. Past affiliations include; Director of Microbiology and Point of Care for the Carolinas Pathology Group, Director and Technical Director for the Mecklenburg County Health Laboratory, Director of the School of Medical Technology for Harrisburg Hospital, CLIA Medical Director for Point of Care, Harrisburg, Pa and Charlotte, NC, Assistant Professor of Pathology for Penn State Hershey Med. Ctr. He serves on the North Carolina response Advisory Group and past member of the Hospital Acquired Infection (HAI) committee. He also is a member of Institutional Biosafety Committee (IBC) for the University of North Carolina Charlotte. He has been the clinical microbiology Chair of the American Society for Microbiology. He also served the Clinical Laboratory Improvement Advisory Committee and Board of Scientific Counselors Office of Infectious Diseases at CDC.

Research Interest

Biography

Dr. Resmi Ravindran’s research has focused on translational research by using the multiplex microbead immunoassay system for detection of biomarkers for chronic infectious diseases. Since 2005, she has worked on developing highly efficient and high throughput multiplex approaches for infectious disease biomarkers (e.g., tuberculosis). In addition, she has employed novel approaches to study disease related biomarkers in bodily fluids by combining the power of multiplexing systems and computational modeling. Results of her research have been published in peer reviewed journals for the development of novel methods for biomarker profiling for infectious diseases.

Research Interest

Research Interest

Soil Science

Research Interest

Neuroanesthesia

Biography

John F. Bebawy, MD is an Associate Professor of Anesthesiology & Neurological Surgery at Northwestern University. His clinical and research interests and expertise relate to Neuroanesthesia, with a focus on interventions that affect cerebral blood flow and cerebrovascular hemodynamics. Dr. Bebawy completed his Anesthesiology residency and Neurosurgical Anesthesiology fellowship training at Northwestern in 2008, where he is currently faculty and Program Director of the Neurosurgical Anesthesiology Fellowship Program. He is a member of many national and international societies for the advancement of Neurosurgical Anesthesiology, has published widely on various topics in the field, and has spoken at many meetings throughout the world on areas within his expertise. Dr. Bebawy is devoted and committed to the betterment of patient safety through individualized and compassionate clinical care, as well as through his contribution to the scientific community.

Research Interest

Molecular Biologist

Research Interest

Biomedicine, Biological Science, Cell & Developmental Biology

Research Interest

Neonatology

Biography

Ghassan Salama is a Consultant Neonatologist and the head of the NICU at Gurayat General Hospital / MOH /KSA. Previously the head of the NICUs at Jordanian Royal medical Services (JRMS). A clinical trainer for medical students at the Faculty of Medicine /Hashemite University/ Jordan. Fellowship in Neonatology at the NICU of the Pediatric department King Hussien Medical Center (JRMS)/Jordan. Visiting neonatologist / Holtz Children’s Hospital @ University of Miami / Miller School of Medicine /USA. Neonatal-perinatal training / Shand’s Hospital @UF/USA. Pediatric residency at Jordanian Royal Medical Services Group Hospitals/Jordan. Interested in nutritional and respiratory support of extremely premature babies.

Research Interest

Colon & Rectal Surgery

Research Interest

Gastroenterology

Research Interest

Stem cell (Embryonic stem cells and Neural stem cells), Embryonic development

Research Interest

Dentistry

Research Interest

Immunology and Microbiology

Biography

Omeed Memar, MD, PhD completed a combined degree from the University of Texas. His dissertation was on induction of autoimmune disease and the mechanism He completed a residency training in dermatology at the University of IIIinosis at Chicago.He has researched the basic science of autoimmunity, carcinogenesis and clinical rejuvenation.His practice of medicine has focused on treating patients with the presentations of aging and dysregulation of aging into cancer formation. He resides in Chicago, Illinois.

Research Interest

Advanced Medical/Surgical/Endoscopic Techniques in Treatment of Sinus, Nasal, Balloon Sinuplasty, Stereotactic Navigational procedures, Minimally Invasive Office

Research Interest

Effects of Mycotoxins on humans

Biography

Dr. Campbell has published over 90 studies in peer-reviewed medical journals and chapters in medical textbooks. Dr. Campbell has received awards from many organizations national and international. He was medical director of the Medical Center for Immune and Toxic Disorders in Houston for 20 years. He lectures regularly at national and international medical conferences, including at Oxford University in England and Harvard University Medical School. Dr. Campbell is currently the editor-in-chief of 2 peer reviewed medical journals, editor of 5 medical journals and is the medical advisor to several companies. He also is conducting a number of clinical trials as principal investigator for supplement companies.